Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wouter V Vogel

Showing results (61-70 of 126) with videos related to

Pageof 13
Sort By:
Head & Neck|February 15, 2019
Parotidectomy in patients with head and neck cutaneous melanoma with cervical lymph node involvementDanique M S Berger, Martinus M van Veen, Max F Madu, et al.
The Laryngoscope|May 3, 2006
FDG-PET in the clinically negative neck in oral squamous cell carcinomaBart M Wensing, Wouter V Vogel, Henri A M Marres, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 17, 2009
Can FDG-PET assist in radiotherapy target volume definition of metastatic lymph nodes in head-and-neck cancer?Dominic A X Schinagl, Aswin L Hoffmann, Wouter V Vogel, et al.
EJNMMI Physics|April 24, 2024
Quantification of biochemical PSA dynamics after radioligand therapy with [<sup>177</sup>Lu]Lu-PSMA-I&T using a population pharmacokinetic/pharmacodynamic modelHinke Siebinga, Berlinda J de Wit-van der Veen, Daphne M V de Vries-Huizing, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 27, 2019
Local and regional treatment response by <sup>18</sup>FDG-PET-CT-scans 4 weeks after concurrent hypofractionated chemoradiotherapy in locally advanced NSCLCJudi N A van Diessen, Matthew La Fontaine, Michel M van den Heuvel, et al.
Clinical Nuclear Medicine|March 20, 2019
The Prognostic Value of Baseline 18F-FDG PET/CT in Human Papillomavirus-Positive Versus Human Papillomavirus-Negative Patients With Oropharyngeal CancerZeno A R Gouw, Matthew D La Fontaine, Simon van Kranen, et al.
European Urology Oncology|March 7, 2026
Diagnostic Value of Fluorine-18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Staging Histological Subtypes of Invasive Bladder CancerRenee A G Lijnen, Joanneke B Ringia, Francesco Claps, et al.
Acta Oncologica (Stockholm, Sweden)|May 16, 2013
Accuracy of 18F-FDG PET/CT for primary tumor visualization and staging in T1 breast cancerBas B Koolen, Femke van der Leij, Wouter V Vogel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 22, 2019
Pre-hydration in cisplatin-based CCRT: Effects on tumour concentrations and treatment outcomeElse A Aalbersberg, Maddalena M Rossi, Linda J de Wit-van der Veen, et al.
European Journal of Radiology|September 4, 2013
Does the pretreatment tumor sampling location correspond with metabolic activity on 18F-FDG PET/CT in breast cancer patients scheduled for neoadjuvant chemotherapy?Bas B Koolen, Lotte E Elshof, Claudette E Loo, et al.
Pageof 13

Showing results (61-70 of 126) with videos related to

Sort By:
Pageof 13
Head & Neck|February 15, 2019
Parotidectomy in patients with head and neck cutaneous melanoma with cervical lymph node involvementDanique M S Berger, Martinus M van Veen, Max F Madu, et al.
The Laryngoscope|May 3, 2006
FDG-PET in the clinically negative neck in oral squamous cell carcinomaBart M Wensing, Wouter V Vogel, Henri A M Marres, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 17, 2009
Can FDG-PET assist in radiotherapy target volume definition of metastatic lymph nodes in head-and-neck cancer?Dominic A X Schinagl, Aswin L Hoffmann, Wouter V Vogel, et al.
EJNMMI Physics|April 24, 2024
Quantification of biochemical PSA dynamics after radioligand therapy with [<sup>177</sup>Lu]Lu-PSMA-I&T using a population pharmacokinetic/pharmacodynamic modelHinke Siebinga, Berlinda J de Wit-van der Veen, Daphne M V de Vries-Huizing, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 27, 2019
Local and regional treatment response by <sup>18</sup>FDG-PET-CT-scans 4 weeks after concurrent hypofractionated chemoradiotherapy in locally advanced NSCLCJudi N A van Diessen, Matthew La Fontaine, Michel M van den Heuvel, et al.
Clinical Nuclear Medicine|March 20, 2019
The Prognostic Value of Baseline 18F-FDG PET/CT in Human Papillomavirus-Positive Versus Human Papillomavirus-Negative Patients With Oropharyngeal CancerZeno A R Gouw, Matthew D La Fontaine, Simon van Kranen, et al.
European Urology Oncology|March 7, 2026
Diagnostic Value of Fluorine-18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Staging Histological Subtypes of Invasive Bladder CancerRenee A G Lijnen, Joanneke B Ringia, Francesco Claps, et al.
Acta Oncologica (Stockholm, Sweden)|May 16, 2013
Accuracy of 18F-FDG PET/CT for primary tumor visualization and staging in T1 breast cancerBas B Koolen, Femke van der Leij, Wouter V Vogel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 22, 2019
Pre-hydration in cisplatin-based CCRT: Effects on tumour concentrations and treatment outcomeElse A Aalbersberg, Maddalena M Rossi, Linda J de Wit-van der Veen, et al.
European Journal of Radiology|September 4, 2013
Does the pretreatment tumor sampling location correspond with metabolic activity on 18F-FDG PET/CT in breast cancer patients scheduled for neoadjuvant chemotherapy?Bas B Koolen, Lotte E Elshof, Claudette E Loo, et al.
Pageof 13